4th European Conference: Perspectives in Inflammatory Bowel Diseases

26. 6. 2009 - 27. 6. 2009, Marriott Copenhagen Hotel, Copenhagen, Denmark

Registrace

  • Zlevněná registrace do 30.4.2009
  • Řádná registrace do 17.6.2009
  • Oznámení
Friday, 26 June 2009
8:30 Welcome and introduction Pia Munkholm, MD, DMSci and Paul Rutgeerts, MD, PhD
Session I:Current therapy of the outpatient with IBD Moderator: Paul Rutgeerts, MD, PhD
8:40 Treatment of the outpatient with ulcerative colitis Pia Munkholm, MD, DMSci
9:05 Treatment of the outpatient with Crohn's disease Pierre Michetti, MD
9:30 Treatment of outpatient pediatric IBD Johanna C. Escher, MD, PhD
9:55 Major side effects of IBD therapies Marc Lémann, MD, PhD
10:20 Coffee break
Session II: Selected topics in IBD I Moderator: Pia Munkholm, MD, DMSci
10:50 Advances in radiological imaging for IBD Andreas Schreyer, MD
11:15 Advances in surgery in IBD Willem A. Bemelman, MD, PhD
11:40 Use of currently available biologics in the treatment of IBD Paul Rutgeerts, MD, PhD
12:05 Future biologic therapy for the treatment of IBD Julián Panés, MD
12:30 Lunch break
Session III: State of the art lecture Moderator: Pia Munkholm, MD, DMSci
14:00 What should I know and do about genetics in IBD? Miles Parkes, MBBS, FRCP
Session IV: Case-based break-out sessions (45 minutes for each, 15 minutes to move to different session, then another 45 minutes)
14:40 Challenges in treating the adolescent with IBD Johanna C. Escher, MD, PhD and Pia Munkholm, MD, DMSci
Challenging medical/surgicalproblems in IBD Willem A. Bemelman, MD, PhD and Julián Panés, MD
Treatment of the outpatient with severe IBD Subrata Ghosh, MD, FRCP and Richard P. MacDermott, MD
15:25 Coffee break
15:40 Challenges in treating theadolescent with IBD Johanna C. Escher, MD, PhD and Pia Munkholm, MD, DMSci
Challenging medical/surgicalproblems in IBD Willem A. Bemelman, MD, PhD and Julián Panés, MD
Treatment of the outpatient withsevere IBD Subrata Ghosh, MD, FRCP and Richard P. MacDermott, MD
16:25 Adjourn
Saturday, 27 June 2009
8:30 Welcome and introduction Pia Munkholm, MD, DMSci and Paul Rutgeerts, MD, PhD
Session V: Selected topics in IBD I Moderator: Philippe Marteau, MD, PhD
8:40 Incorporating new endoscopictechnologies into clinical practice Ralf Kiesslich, MD
9:05 Treatment of common ano-rectalproblems in IBD Geert D’Haens, MD, PhD
9:30 ECCO consensus on vaccinationrecommendations for IBD Jean-Frédéric Colombel, MD
9:55 Use of antibiotics and probiotics in IBD Philippe Marteau, MD, PhD
10:20 Coffee break
Session VI: Debates: Controversies in IBD Moderator: Richard P. MacDermott, MD
DEBATE 1
10:50 Pro: Mucosal healing is a clinically relevant clinical endpoint in all patients with ulcerative colitis Paul Rutgeerts, MD, PhD
11:05 Con: Mucosal healing is not a relevantclinical endpoint in any patient with ulcerative colitis Subrata Ghosh, MD, FRCP
11:20 Question and answer and panel discussion
DEBATE 2:
11:40 Pro: Biologics should be used before immunomodulators in Crohn's disease Geert D' Haens, MD, PhD
11:55 Con: Immunomodulators should beused before biologics in Crohn's disease Gert Van Assche, MD, PhD
12:10 Question and answer and panel discussion
12:30 Lunch break
Session VII: Case-based break-out sessions (45 minutes for each, 15 minutes to move to different session, then another 45 minutes)
14:00 Cancer surveillance in Crohn's disease andulcerative colitis: What should we do about low gradedysplasia, polyps and DALMlesions? Ralf Kiesslich, MD and Pierre Michetti, MD
Diagnosis, treatment, and prevention ofinfectious complications of IBD Jean-Frédéric Colombel, MD and Philippe Marteau, MD, PhD
Treatment of the inpatient with severe IBD Marc Lémann, MD, PhD and Gert Van Assche, MD, PhD
14:45 Coffee break
15:00 Cancer surveillance in Crohn's disease and ulcerative colitis: What should we do about low gradedysplasia, polyps and DALM lesions? Ralf Kiesslich, MD and Pierre Michetti, MD
Diagnosis, treatment, and prevention ofinfectious complications of IBD Jean-Frédéric Colombel, MD and Philippe Marteau, MD, PhD
Treatment of the inpatient with severe IBD Marc Lémann, MD, PhD and Gert Van Assche, MD, PhD
15:45 Adjourn

Kontakt: meetings@imedex.com

Web: http://www.imedex....ements/a070-01.asp

  • Sdílejte na:
    • Facebook
    • Twitter
    • Del.icio.us
    • Digg
    • Google
    • Reddit
    • StumbleUpon
    • Live

Podpora ČOS

Podpora Linkos.cz 

Děkujeme za podporu Linkos.cz! 

I my podporujeme 

Mezi členy ČOS je mnoho DOBRÝCH ANDĚLŮ, kteří přispívají rodinám, jež se vinou nemoci dostali do finanční tísně, ale také těch, kteří zprostředkují pomoc nadace DOBRÝ ANDĚL svým pacientům.